** Medical device maker Insulet's PODD.O shares rise 10.2% to $283.20 premarket
** Insulet late on Thursday beat Q1 profit estimates, buoyed by strong demand for its wearable insulin pumps
** Company earned $1.02 per share, above analysts' average estimate of 80 cents per share - data compiled by LSEG
** Company now expects its annual revenue to grow between 19% and 22%, compared with its previous projection of 16% to 20%
** Company's Q1 total revenue increased 28.8% to $569 million, compared with analysts' estimates of $543.4 million
** As of last close, stock down 1.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。